Single-Site Investigator-Initiated Clinical Trials (R61/R33)

This Funding Opportunity Announcement (FOA) supports applications to develop and implement phase II and beyond investigator-initiated single-site clinical trials.

Applications submitted to this FOA must be relevant to the research mission of the NHLBI and meet the NIH definition of a clinical

credit:


trial (see NOT-OD-15-015).

For additional information about the mission, strategic vision, and research priorities of the NHLBI, applicants are encouraged to consult the NHLBI website:
http://www.nhlbi.nih.gov.

This FOA will utilize a bi-phasic, milestone-driven mechanism of award.

It is anticipated that applications will present the scientific rationale for the clinical trial and a comprehensive scientific and operational plan that describes the conduct of the trial, as well as plans for project management, subject recruitment and retention, performance milestones, scientific conduct of the trial, and dissemination of results.
Related Programs

National Center on Sleep Disorders Research

Department of Health and Human Services


Cardiovascular Diseases Research

Department of Health and Human Services


Lung Diseases Research

Department of Health and Human Services


Blood Diseases and Resources Research

Department of Health and Human Services


Agency: National Institutes of Health

Office:

Estimated Funding: $40,000


Who's Eligible





Obtain Full Opportunity Text:
http://grants.nih.gov/grants/guide/pa-files/PAR-16-405.html

Additional Information of Eligibility:
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U. S. Territory or Possession.

Full Opportunity Web Address:


Contact:


Agency Email Description:


Agency Email:
FBOWebmaster@OD.NIH.GOV

Date Posted:
2016-08-15

Application Due Date:
2019-09-13

Archive Date:
2019-10-14


Co-founders William Mann and David Mravyan devised the Sensimat during a mandatory project for their MBA at the Richard Ivey School of Business in Canada. Sensimat is a device that helps manage and assess pressure among wheelchair users.






More Federal Domestic Assistance Programs


OVW Technical Assistance Initiative | Missing Alzheimer"s Disease Patient Assistance Program | Wildlife Services | Surveys, Studies, Investigations, Training Demonstrations and Educational Outreach Related to Enviro | Minority Health and Health Disparities Research |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2024 Copyright Michael Saunders